Next Article in Journal
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease
Previous Article in Journal
Algerian Prickly Pear Seed By-Products: Fatty Acids Composition, Antioxidant, Enzyme Inhibitory Activities towards Tyrosinase, Urease, α-Amylase, and Cholinesterase, along with the Ability to Protect from Thermal Protein Denaturation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 17
Issue 9
10.3390/ph17091146
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Pharmaceuticals 2024, 17(2), 171.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Haddad et al. Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii. Pharmaceuticals 2024, 17, 171

by
Houda Haddad
1,2,
Radhia Mejri
2 and
Amira Zaïri
2,*
1
BIOLIVAL Laboratory, LR14ES06, The Higher Institute of Biotechnology of Monastir ISBM, University of Monastir, Monastir 5000, Tunisia
2
Biochemistry Department, LR18ES47, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2024, 17(9), 1146; https://doi.org/10.3390/ph17091146
Submission received: 15 August 2024 / Accepted: 21 August 2024 / Published: 30 August 2024
Versions Notes
Removal of an Author
Alyne Rodrigues de Araujo requested to remove his name from the original publication [1] because he did not participate in the analysis of the original data presented in this paper. The corrected Author Contributions statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Author Contributions: This manuscript is the overall collaborative work of the participants. Writing, Methodology, Conceptualization, H.H.; Review-Validation, R.M.; Supervision, Review & Editing, A.Z. All authors have read and agreed to the published version of the manuscript.

Reference

  1. Haddad, H.; Mejri, R.; Zaïri, A. Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii. Pharmaceuticals 2024, 17, 171. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Haddad, H.; Mejri, R.; Zaïri, A. Correction: Haddad et al. Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii. Pharmaceuticals 2024, 17, 171. Pharmaceuticals 2024, 17, 1146. https://doi.org/10.3390/ph17091146

AMA Style

Haddad H, Mejri R, Zaïri A. Correction: Haddad et al. Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii. Pharmaceuticals 2024, 17, 171. Pharmaceuticals. 2024; 17(9):1146. https://doi.org/10.3390/ph17091146

Chicago/Turabian Style

Haddad, Houda, Radhia Mejri, and Amira Zaïri. 2024. "Correction: Haddad et al. Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii. Pharmaceuticals 2024, 17, 171" Pharmaceuticals 17, no. 9: 1146. https://doi.org/10.3390/ph17091146

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop